Adipose-tissue Derived Stem Cells in Flaps Versus Liposuction

Status Completed

Clinical Trial Summary

The aim of the study is to evaluate a physiological concentration of adipose tissue-derived stem cells (ASC) in excised fat versus fat harvested by liposuction. Participants will act as their own control as both extraction methods are performed on each participant.

Clinical Trial Description

Adipose tissue-derived stem cells are of great interest due to their relevance in regenerative medicine and tissue engineering. A reason, being their capacity for multipotent differentiation, tissue repair and immune modulation.

To evaluate a physiological concentration level of ASCs in human fat we investigate two extraction methods of fat, excision and liposuction. This is done through a standardised setup with patients acting their own control. The study is carried out in accordance with the guidelines provided by the International Federation for Adipose Therapeutics and Science and International Society for Cellular Therapy. ;

Study Design

Related Conditions & MeSH terms

Mesenchymal Stem Cells

Clinical Trial Details

NCT number	NCT03105284
Study type	Interventional
Source	University of Aarhus
Contact
Status	Completed
Phase	N/A
Start date	September 1, 2016
Completion date	August 31, 2017

View Details

See also
Status	Clinical Trial	Phase
Active, not recruiting	`NCT01219465` - Umbilical Cord Mesenchymal Stem Cells Infusion for Initial Type 1 Diabetes Mellitus	Phase 1/Phase 2
Active, not recruiting	`NCT01221428` - Umbilical Cord Mesenchymal Stem Cells Infusion for Ulcerative Colitis	Phase 1/Phase 2
Not yet recruiting	`NCT01224327` - Umbilical Cord Mesenchymal Stem Cells Infusion Via Hepatic Artery in Cirrhosis Patients	Phase 1/Phase 2
Recruiting	`NCT06149832` - Treatment of Oral Chronic Graft-versus-host Disease With Human Umbilical Cord Mesenchymal Stem Cell Dressing	Phase 4
Recruiting	`NCT05165459` - Open Label Single Arm Proof of Concept Trial to Evaluate the Efficacy and Safety of Cytori Celution System in Chronic Non-Healing Venous Leg Ulcers	N/A
Active, not recruiting	`NCT04014166` - Study of Human Umbilical Cord-derived Mesenchymal Stem Cells for Treatment of Refractory Immune Thrombocytopenia	N/A
Not yet recruiting	`NCT06077734` - Muscle Stem Cell Quality in Atrophy
Completed	`NCT00956891` - Therapeutic Effects of Liver Failure Patients Caused by Chronic Hepatitis B After Autologous MSCs Transplantation	Phase 1/Phase 2
Recruiting	`NCT01218464` - Safety and Efficacy of Human Mesenchymal Stem Cells for Treatment of Liver Failure	Phase 1/Phase 2
Active, not recruiting	`NCT03874572` - Allogeneic Mesenchymal Stem Cells for Radiation-induced Hyposalivation and Xerostomia/Dry Mouth	Phase 1
Recruiting	`NCT00953485` - Allogeneic Mesenchymal Stem Cells Transplantation for Primary Sjögren's Syndrome (pSS)	Phase 1/Phase 2
Not yet recruiting	`NCT04863183` - Cell Therapy With Cellistem-OA for Symptomatic Knee Osteoarthritis	Phase 1/Phase 2
Completed	`NCT06360861` - Evaluate the Safety and Feasibility of Allogeneic Mesenchymal Stem Cells in Patients With Multiple Sclerosis	Phase 1
Completed	`NCT05018754` - Treatment of Oral Mucositis Using Platelet Rich Fibrin TREATMENT OF ORAL MUCOSITIS USING PRF
Recruiting	`NCT04356287` - Treatment With Human Umbilical Cord-derived Mesenchymal Stromal Cells in Systemic Sclerosis	Phase 1/Phase 2
Completed	`NCT03130374` - Treatment of Laryngotracheal Stenosis Using Mesenchymal Stem Cells	Phase 1/Phase 2
Active, not recruiting	`NCT02673788` - Follow-Up Study of Safety of Pneumostem® in Premature Infants With Intraventricular Hemorrhage
Recruiting	`NCT01763099` - Mesenchymal Stem Cells Combined With Cord Blood for Treatment of Graft Failure	Phase 2
Recruiting	`NCT01763086` - Mesenchymal Stem Cells for Treatment of Poor Graft Function After Allogeneic Hematopoietic Stem Cell Transplant	Phase 2
Completed	`NCT02302599` - Mesenchymal Stem Cells to Treat Type 2 Diabetes	Phase 2